Interleukin‐37 promotes DMBA/TPA skin cancer through SIGIRR‐mediated inhibition of glycolysis in CD103(+)DC cells

por Zeng, Fan‐lian, Wang, Xiao‐yan, Hu, Ya‐wen, Wang, Zhen, Li, Ya, Hu, Jing, Yu, Jia‐dong, Zhou, Pei, Teng, Xiu, Zhou, Hong, Zheng, Hua‐ping, Zhao, Fu‐lei, Gu, Lin‐na, Yue, Cheng‐cheng, Chen, Shu‐wen, Cheng, Juan, Hao, Yan, Zhao, Qi‐xiang, Zhang, Chen, Zou, Song, Hu, Zhong‐lan, Wei, Xiao‐qiong, Liu, Xiao, Li, Guo‐lin, Huang, Nong‐yu, Wu, Wen‐ling, Zhou, Yi‐fan, Li, Wei, Cui, Kaijun, Li, Jiong
Publicado 2023

Interleukin-37 promotes colitis-associated carcinogenesis via SIGIRR-mediated cytotoxic T cells dysfunction

por Wang, Zhen, Zeng, Fan-lian, Hu, Ya-wen, Wang, Xiao-yan, Zhao, Fu-lei, Zhou, Pei, Hu, Jing, Xiao, Yuan-yuan, Hu, Zhong-lan, Guo, Ming-feng, Wei, Xiao-qiong, Liu, Xiao, Huang, Nong-yu, Zhang, Jun, Chen, Shu-wen, Cheng, Juan, Zheng, Hua-ping, Zhou, Hong, Zhao, Qi-xiang, Zhang, Chen, Hao, Yan, Zou, Song, Gui, Yi-yue, Yu, Jia-dong, Gu, Lin-na, Yue, Cheng-cheng, Zhang, Hao-zhou, Wu, Wen-ling, Zhou, Yi-fan, Zhou, Xi-kun, Shen, Guo-bo, Teng, Xiu, Li, Jiong
Publicado 2022